Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Aquaporin initiates rights issue
      Biotech

      Aquaporin initiates rights issue

      December 19, 2025
      Jazz Pharmaceuticals to Participate in Upcoming Investor Events
      Biotech

      Jazz Pharmaceuticals to Participate in Upcoming Investor Events

      December 18, 2025
      Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
      Biotech

      Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology

      December 17, 2025
      Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025
      Biotech

      Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025

      December 16, 2025
      Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor
      Biotech

      Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor

      December 15, 2025
      Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
      Biotech

      Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout

      December 14, 2025
      NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor
      Biotech

      NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor

      December 13, 2025
      FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
      Biotech

      FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS

      December 12, 2025
      Nuvalent Appoints Ron Squarer to Board of Directors
      Biotech

      Nuvalent Appoints Ron Squarer to Board of Directors

      December 11, 2025
      BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair
      Biotech

      BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair

      December 10, 2025
      « 1 … 6 7 8 9 10 … 133 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026